-
1
-
-
0018091156
-
-
(a) Clark, R. L.; Pessolano, A. A.; Shen, T.-Y.; Jacobus, D. P.; Jones, H.; Lotti, V. J.; Flataker, L. M. J. Med. Chem. 1978, 21, 965.
-
(1978)
J. Med. Chem.
, vol.21
, pp. 965
-
-
Clark, R.L.1
Pessolano, A.A.2
Shen, T.-Y.3
Jacobus, D.P.4
Jones, H.5
Lotti, V.J.6
Flataker, L.M.7
-
3
-
-
33748279157
-
-
US Patent 3819640, 1974
-
(c) von Bebenberg, W. US Patent 3819640, 1974.
-
-
-
Von Bebenberg, W.1
-
4
-
-
6344241725
-
-
FP 2478637,1981
-
(d) Lesher, O. Y.; Brundage, R. P.; Opalka, C. J.; Page, D. F. FP 2478637,1981; Chem. Abstr. 1982, 96, 85551k.
-
(1982)
Chem. Abstr.
, vol.96
-
-
Lesher, O.Y.1
Brundage, R.P.2
Opalka, C.J.3
Page, D.F.4
-
5
-
-
0020286964
-
-
(e) Kuezynski, L.; Mrozikiewiez, A.; Poreba, K. Pol. J. Pharmacol. Pharm. 1982, 34, 229.
-
(1982)
Pol. J. Pharmacol. Pharm.
, vol.34
, pp. 229
-
-
Kuezynski, L.1
Mrozikiewiez, A.2
Poreba, K.3
-
6
-
-
0021051365
-
-
(f) Bianchi, M.; Butti, A.; Rossi, S.; Barzaghi, F.; Marcaria, V. Eur. J. Med. Chem. 1983, 18, 501.
-
(1983)
Eur. J. Med. Chem.
, vol.18
, pp. 501
-
-
Bianchi, M.1
Butti, A.2
Rossi, S.3
Barzaghi, F.4
Marcaria, V.5
-
7
-
-
33748251346
-
-
US Patent 2637731, 1953
-
(g) Vaughn, J. R. Jr. US Patent 2637731, 1953.
-
-
-
Vaughn Jr., J.R.1
-
9
-
-
0028911233
-
-
Meanwell, N. A.; Sit, S. Y.; Gao, J.; Wong, H. S.; Gao, Q.; St. Laurent, D. R.; Balasubramanian, N. J. Org. Chem. 1995, 60, 1565.
-
(1995)
J. Org. Chem.
, vol.60
, pp. 1565
-
-
Meanwell, N.A.1
Sit, S.Y.2
Gao, J.3
Wong, H.S.4
Gao, Q.5
St. Laurent, D.R.6
Balasubramanian, N.7
-
10
-
-
6344277027
-
-
Kuethe, J. T.; Wong, A.; Davies, I. W. J. Org. Chem. 2004, 69, 7752.
-
(2004)
J. Org. Chem.
, vol.69
, pp. 7752
-
-
Kuethe, J.T.1
Wong, A.2
Davies, I.W.3
-
12
-
-
0038579438
-
-
Huang, X.; Anderson, K. W.; Zim, D.; Jiang, L.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc. 2003, 125, 6653.
-
(2003)
J. Am. Chem. Soc.
, vol.125
, pp. 6653
-
-
Huang, X.1
Anderson, K.W.2
Zim, D.3
Jiang, L.4
Klapars, A.5
Buchwald, S.L.6
-
13
-
-
33748281610
-
-
(a) Horino, H.; Ishiyama, T.; Tatematsu, T.; Makino, C.; Ochiai, Y.; Kito, K.; Kanaya, N.; Hishida, K. Chem. Abstr. 2001, 135, 166835.
-
(2001)
Chem. Abstr.
, vol.135
, pp. 166835
-
-
Horino, H.1
Ishiyama, T.2
Tatematsu, T.3
Makino, C.4
Ochiai, Y.5
Kito, K.6
Kanaya, N.7
Hishida, K.8
-
14
-
-
0035036499
-
-
(b) Li, J.; Zheng, L.-M.; King, I.; Doyle, T.; Chen, S.-H. Curr. Med. Chem. 2001, 8, 121.
-
(2001)
Curr. Med. Chem.
, vol.8
, pp. 121
-
-
Li, J.1
Zheng, L.-M.2
King, I.3
Doyle, T.4
Chen, S.-H.5
-
15
-
-
0032482306
-
-
(c) Niu, C.; Li, J.; Doyle, T. W.; Chen, S.-H. Tetrahedron 1998, 54, 6311.
-
(1998)
Tetrahedron
, vol.54
, pp. 6311
-
-
Niu, C.1
Li, J.2
Doyle, T.W.3
Chen, S.-H.4
-
17
-
-
33748277456
-
-
note
-
2 was added a solution of 2-chloro-3-aminopyridine (40.9 g, 318 mmol) in THF (80 mL) over
-
-
-
-
18
-
-
33748253334
-
-
note
-
+.
-
-
-
-
19
-
-
33748273936
-
-
note
-
BINAP and dppf were found to be inferior for the formation of 2a than XantPhos.
-
-
-
-
20
-
-
0001029926
-
-
First reported by van Leeuwen: Kranenberg, M.; van der Burgt, Y. E. M.; Kamer, P. C. J.; van Leeuwen, P. W. N. M. Organometallics 1995, 14, 3081.
-
(1995)
Organometallics
, vol.14
, pp. 3081
-
-
Kranenberg, M.1
Van Der Burgt, Y.E.M.2
Kamer, P.C.J.3
Van Leeuwen, P.W.N.M.4
-
21
-
-
33748250117
-
-
note
-
XantPhos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene.
-
-
-
-
23
-
-
33748265342
-
-
note
-
The THF used in our study had a water content between 60 mg/mL and 110 mg/mL as determined by Karl-Fischer titration. (15) The approach used in Scheme 2 for the construction of 3-phenyl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one has not been previously reported and given the diversity of commercially available isocyanates, may constitute another general entry to compounds in this class.
-
-
-
-
24
-
-
33748272557
-
-
note
-
All new compounds gave satisfactory spectroscopic characterisation data.
-
-
-
-
25
-
-
33748275944
-
-
note
-
Alkylamines screened were cyclopropylamine, sec-butylamine, (R)-1-phenylethylamine and 1-(2-aminoethyl)-piperidine. In all instances <20A% of desired imidazopyridin-2-one was identified by LCMS using either THF or toluene-i-PrOH (4:1) as reaction solvent.
-
-
-
-
26
-
-
14844330054
-
-
Use of a Josiphos ligand for amination of 2-chloropyridine with primary alkylamines has been recently reported: Shen, Q.; Shekhar, S.; Stambuli, J. P.; Hartwig, J. F. Angew. Chem. Int. Ed. 2005, 44, 1371.
-
(2005)
Angew. Chem. Int. Ed.
, vol.44
, pp. 1371
-
-
Shen, Q.1
Shekhar, S.2
Stambuli, J.P.3
Hartwig, J.F.4
-
27
-
-
33748266940
-
-
note
-
3/BINAP as catalyst system for amination.
-
-
-
|